UA41048U - Method for prediction of invasive and metastatic activity of cancer of mammary gland - Google Patents

Method for prediction of invasive and metastatic activity of cancer of mammary gland

Info

Publication number
UA41048U
UA41048U UAU200901030U UAU200901030U UA41048U UA 41048 U UA41048 U UA 41048U UA U200901030 U UAU200901030 U UA U200901030U UA U200901030 U UAU200901030 U UA U200901030U UA 41048 U UA41048 U UA 41048U
Authority
UA
Ukraine
Prior art keywords
invasive
prediction
cancer
mammary gland
metastatic activity
Prior art date
Application number
UAU200901030U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Дмитрий Александрович Микитенко
Original Assignee
Дмитрий Александрович Микитенко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дмитрий Александрович Микитенко filed Critical Дмитрий Александрович Микитенко
Priority to UAU200901030U priority Critical patent/UA41048U/en
Publication of UA41048U publication Critical patent/UA41048U/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Method for prediction of invasive and metastatic activity of cancer of mammary gland includes sampling of material under investigation, reveal of expression of key molecular marker – albumen E-cadgerin, and evaluation of invasive and metastatic potential of tumor. As material under investigation one chooses blood plasma where one determines level of homocistein. One determines range of level of expression of E-kadgerins.
UAU200901030U 2009-02-09 2009-02-09 Method for prediction of invasive and metastatic activity of cancer of mammary gland UA41048U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200901030U UA41048U (en) 2009-02-09 2009-02-09 Method for prediction of invasive and metastatic activity of cancer of mammary gland

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200901030U UA41048U (en) 2009-02-09 2009-02-09 Method for prediction of invasive and metastatic activity of cancer of mammary gland

Publications (1)

Publication Number Publication Date
UA41048U true UA41048U (en) 2009-04-27

Family

ID=50620563

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200901030U UA41048U (en) 2009-02-09 2009-02-09 Method for prediction of invasive and metastatic activity of cancer of mammary gland

Country Status (1)

Country Link
UA (1) UA41048U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646787C1 (en) * 2017-04-26 2018-03-07 федеральное государственное бюджетное образовательное учреждение высшего образования "Новосибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НГМУ Минздрава России) Method of determination of the metastatic potential of breast

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646787C1 (en) * 2017-04-26 2018-03-07 федеральное государственное бюджетное образовательное учреждение высшего образования "Новосибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НГМУ Минздрава России) Method of determination of the metastatic potential of breast

Similar Documents

Publication Publication Date Title
AU2017225061B2 (en) Biomarkers and methods of treating PD-1 and PD-L1 related conditions
MX2013002084A (en) Biomarkers and methods of treatment.
WO2011088149A3 (en) Methods for predicting response of triple-negative breast cancer to therapy
ZA200702973B (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
EA200901074A1 (en) TREATMENT OF THE METASTATIC STAGE OF PROSTATE CANCER WITH DEGARELIX
CY1123716T1 (en) ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC, EUNAUCH-RESISTANT PROSTATE CANCER
EA201290901A1 (en) PHYTOCANNABINOIDS FOR THE TREATMENT OF MALIGNANT TUMOR
IL207637A (en) Drug selection for breast cancer therapy using antibody-based arrays
MX2015004610A (en) Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf.
EP3106168A3 (en) Targeting micrornas mir-409-5p, mir-379 and mir-154* to treat prostate cancer bone metastasis and drug resistant lung cancer
WO2011094335A3 (en) Microrna signatures predicting responsiveness to anti-her2 therapy
WO2009092108A3 (en) Biomarkers for the diagnosis and treatment of pancreatic cancer
WO2005094348A3 (en) Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer
WO2006095086A3 (en) Traceability of cellular cycle anomalies targeting oncology and neurodegeneration
WO2013025952A3 (en) Methods and compositions for the treatment and diagnosis of breast cancer
WO2009004484A3 (en) Trim24 (tifla) as p53 modulator and cancer target
WO2009019370A3 (en) Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer
MX336761B (en) Compounds for treatment of cancer.
EP3385717A3 (en) Methods of detecting prostate cancer
WO2012087144A3 (en) Methods and means for molecular classification of colorectal cancers
MX2016004304A (en) Conjugated antibodies against ly75 for the treatment of cancer.
WO2009020645A3 (en) Matriptase protein and uses thereof
WO2009124281A3 (en) Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis
WO2008063760A3 (en) Methods for treating cancer targeting transglutaminase
WO2008134752A3 (en) Methods and compositions for the treatment of cancer